American Journal of Epidemiology
Discipline Public health, Medicine
Language English language
Edited by Enrique Schisterman
Publication details
Publisher
Oxford University Press for the Johns Hopkins Bloomberg School of Public Health (United States)
Frequency Semi-monthly
Impact factor
4.473 (2018)
Standard abbreviations
ISO 4 Am. J. Epidemiol.
Indexing
ISSN 0002-9262 (print)
1476-6256 (web)
Links
Journal homepage
The American Journal of Epidemiology (AJE) is a peer-reviewed journal for empirical research findings, opinion pieces, and methodological developments in the field of epidemiological research. The current Editor-in-Chief is Dr. Enrique Schisterman.
Articles published in AJE are indexed by PubMed, Embase, and a number of other databases. AJE offers open access options for authors. It is published semi-monthly. Entire issues have been dedicated to abstracts from academic meetings (Society of Epidemiologic Research, North American Congress of Epidemiology), the history of the Epidemic Intelligence Service of the Centers for Disease Control and Prevention (CDC),[1] the life of George W. Comstock,[2] and the celebration of notable anniversaries of schools of public health (University of California, Berkeley, School of Public Health;[3] Tulane University School of Public Health and Tropical Medicine;[4] Johns Hopkins Bloomberg School of Public Health).
AJE is currently ranked 5th in the field of epidemiology according to Google Scholar.[5] It has an impact factor of 4.473 (as of 2018) and the 5-year impact factor is 5.419 according to Journal Citation Reports.[6].
A medical journal does not place "peer-reviewed" on its masthead. Sorry to disappoint you. Perhaps you should include the AJE as one of your medical sources that you read. It would be edifying than techstartups.com. with regard to medical issues.
American Journal of Epidemiology
Discipline Public health, Medicine
Language English language
Edited by Enrique Schisterman
Publication details
Publisher
Oxford University Press for the Johns Hopkins Bloomberg School of Public Health (United States)
Frequency Semi-monthly
Impact factor
4.473 (2018)
Standard abbreviations
ISO 4 Am. J. Epidemiol.
Indexing
ISSN 0002-9262 (print)
1476-6256 (web)
Links
Journal homepage
The American Journal of Epidemiology (AJE) is a peer-reviewed journal for empirical research findings, opinion pieces, and methodological developments in the field of epidemiological research. The current Editor-in-Chief is Dr. Enrique Schisterman.
Articles published in AJE are indexed by PubMed, Embase, and a number of other databases. AJE offers open access options for authors. It is published semi-monthly. Entire issues have been dedicated to abstracts from academic meetings (Society of Epidemiologic Research, North American Congress of Epidemiology), the history of the Epidemic Intelligence Service of the Centers for Disease Control and Prevention (CDC),[1] the life of George W. Comstock,[2] and the celebration of notable anniversaries of schools of public health (University of California, Berkeley, School of Public Health;[3] Tulane University School of Public Health and Tropical Medicine;[4] Johns Hopkins Bloomberg School of Public Health).
AJE is currently ranked 5th in the field of epidemiology according to Google Scholar.[5] It has an impact factor of 4.473 (as of 2018) and the 5-year impact factor is 5.419 according to Journal Citation Reports.[6].
A medical journal does not place "peer-reviewed" on its masthead. Sorry to disappoint you. Perhaps you should include the AJE as one of your medical sources that you read. It would be edifying than techstartups.com. with regard to medical issues.
OPEN ACCESS OPTIONS FOR AUTHORS....bolded...what does that mean? Is "open access option"/peer reviewed or is it an opinion piece WITHOUT review? THAT makes a huge difference in
content of this article.
HA, you disappoint me. Of course, the article by Dr. Risch is an opinion.
Obviously you did not read it.
Harvey Risch, M.D., Ph.D., is a professor of epidemiology at the Yale University School of Medicine.
He is a member of the Board of Editors of the American Journal of Epidemiology.
Editors write opinion pieces, also known as editorials.
ramage wrote: HA, you disappoint me. Of course, the article by Dr. Risch is an opinion.
Obviously you did not read it.
Harvey Risch, M.D., Ph.D., is a professor of epidemiology at the Yale University School of Medicine.
He is a member of the Board of Editors of the American Journal of Epidemiology.
Editors write opinion pieces, also known as editorials.
SC can u define open access option? Is that SYNONYMOUS with peer reviewed? From my reading
of the phrase, it is NOT peer reviewed,but rather an opinion, which has not been verified by the med.
experts in the field.....and is allowed to be presented in a POV article.
HA, is this your attempt at humor? Editorials/opinion pieces are just that; a statement of one's view supported by evidence. By definition if an editorial/opinion piece were to be "peer reviewed" what would result is the opinion of that "peer". An opinion is not verified.
What I do find humous is "med experts in the field"
Harvey Risch, M.D., Ph.D., is a professor of epidemiology at the Yale University School of Medicine.
He is a member of the Board of Editors of the American Journal of Epidemiology, he is an author of more than 300 original research publications in the medical literature,
If he is not a "med expert", I am curious to see what you consider a "med expert", please enlighten me.
From zerohedge.com 6/3/20 In reference to the resumption of the HCQ study.
World Health Organization (WHO)
✔
@WHO
"On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol"-@DrTedros #COVID19
28
10:05 AM - Jun 3, 2020
Last edit: 03 Jun 2020 10:43 by ramage. Reason: Overlap of quotes
homeagain wrote: SC can u define open access option? Is that SYNONYMOUS with peer reviewed? From my reading
of the phrase, it is NOT peer reviewed,but rather an opinion, which has not been verified by the med.
experts in the field.....and is allowed to be presented in a POV article.
Open access has nothing to do with peer reviewed, it simply means that the article is not behind a paywall - it's access is literally open to everyone.
The journal is a respectable, peer-reviewed research publication and if the manuscript was accepted, it means it underwent some kind of review. The article is a meta-review of other studies conducted on hydroxychloroquine, not direct research itself, similar to what ramage pointed out about The Lancet study cited recently.
Do note the conflict of interest that is stated upfront in the article:
Dr. Risch acknowledges past advisory consulting work with two of the more than 50 manufacturers of hydroxychloroquine, azithromycin and doxycycline. This past work was not related to any of these three medications and was completed more than two years ago. He has no ongoing, planned or projected relationships with any of these companies, nor any other potential conflicts-of-interest to disclose.
Speaking of The Lancet study, it has now been retracted
due to concerns about the veracity of the primary data sources.
On its face, it was a major finding: Anti-malarial drugs touted by the White House as possible COVID-19 treatments looked to be not just ineffective, but downright deadly. A study published on 22 May in The Lancet used hospital records procured by a little-known data analytics company called Surgisphere to conclude that COVID-19 patients taking chloroquine or hydroxychloroquine were more likely to show an irregular heart rhythm—a known side effect thought to be rare—and more likely to die. Within days, large randomized trials of the drugs screeched to a halt. Solidarity, the World Health Organization’s (WHO’s) megatrial of potential COVID-19 treatments, paused recruitment into its hydroxychloroquine arm.
But just as quickly, the results have begun to unravel—and Surgisphere, which provided patient data for two other high-profile COVID-19 papers, has come under withering online scrutiny from researchers and amateur sleuths. They have pointed out many red flags in the Lancet paper, including the astonishing number of patients and details about patient demographics and dosing that seemed implausible.
"Now, more than ever, the illusions of division threaten our very existence. We all know the truth: more connects us than separates us. But in times of crisis the wise build bridges, while the foolish build barriers. We must find a way to look after one another as if we were one single tribe.” -King T'Challa, Black Panther
The truth is incontrovertible. Malice may attack it. ignorance may deride it, but in the end, there it is. ~Winston Churchill
FredHayek wrote: So today Lancet says one of the anti Hydro studies is very suspect. This angers me. Why does everything have to be political?
BECAUSE there is NO UNDERSTANDING of this present medical condition....AGAIN, it is 52 card P.U.....I
just has a conversation with a triage nurse.....about protocol,the present info,the process that is being
used to work the problem...her EXACT WORDS..."no one really knows"....from the horses mouth.
The reality of the virus is this..we are stuck with-it till there herd immunity....the promised vaccine MAY
work,but since it is being PUSHED THRU without due diligence...there is a question of IF it will work and
for what period of time....NJMO